Elios Therapeutics, LLC   Report issue

For profit Phase 2
Founded: Austin TX United States (2014)
Status: Left NME R&D (2021)

Organization Overview

First Clinical Trial
2015
NCT02301611
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Elios Therapeutics, LLC